Boehringer Ingelheim gets USFDA nod for SPEVIGO to treat generalized pustular psoriasis flares Ruchika Sharma3 Sept 2022 11:00 AM ISTRidgefield: Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (USFDA) has approved SPEVIGO, the first approved treatment...
Lupin to acquire diabetes brands Ondero, Ondero-Met from Boehringer Ingelheim for Rs 207 crore Ruchika Sharma25 Aug 2022 3:30 PM ISTNew Delhi: Lupin Limited is soon going to acquire two diabetes brands Ondero and Ondero - Met from Boehringer Ingelheim International GmbH for Rs...
Boehringer Ingelheim, Evotec and bioMérieux launch joint venture Aurobac Ruchika Sharma10 July 2022 2:00 PM ISTFrance: Boehringer Ingelheim, a research-driven biopharmaceutical company, the life science company Evotec SE and bioMérieux have announced that they...
Boehringer Ingelheim, CarthroniX ink pact to pursue small molecule therapeutics in canine oncology Ruchika Sharma19 Jun 2022 2:30 PM ISTUnder the agreement, Boehringer Ingelheim will test a select group of small molecules provided by CarthroniX with the goal of determining their impact...
HC restrains pharma companies from infringing Boehringer Ingelheim diabetes drug Linagliptin Susmita Roy8 Jun 2022 4:04 PM ISTNew Delhi: In a major relief to pharmaceuticals major Boehringer Ingelheim, the High Court has restrained four domestic pharma companies namely,...
Boehringer Ingelheim, A*STAR ink pact for targeted cancer therapies Ruchika Sharma4 Jun 2022 10:00 AM ISTA*STAR may receive payments totalling 100 million EUR in upfront and success-based development and commercialization milestones.
Boehringer Ingelheim's empagliflozin gets CDSCO nod for heart failure with preserved ejection fraction Medical Dialogues Bureau19 May 2022 4:19 PM ISTNew Delhi: Boehringer Ingelheim, one of the world's leading, research-driven pharmaceutical companies, has received approval from the Central Drugs...
USFDA okays Alembic Pharma Dabigatran Etexilate Capsules Ruchika Sharma7 April 2022 3:41 PM ISTDabigatran Etexilate capsules, are indicated for reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult...
Boehringer operating income edges up on Jardiance, animal health Ruchika Sharma6 April 2022 9:00 AM ISTFrankfurt: Germany's unlisted Boehringer Ingelheim said operating income rose 1.8% in 2021, driven by more prescriptions of diabetes drug Jardiance...
Boehringer Ingelheim gets USFDA Breakthrough Therapy Designation for BI 1015550 MD Bureau28 Feb 2022 11:00 AM ISTGermany: Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (USFDA) has granted Breakthrough Therapy Designation to its...
Eli Lilly, Boehringer Ingelheim gets USFDA nod for Jardiance to treat heart failure regardless of ejection fraction MD Bureau26 Feb 2022 11:00 AM ISTIndianapolis: Eli Lilly and Company and Boehringer Ingelheim have recently announced that the U.S. Food and Drug Administration (USFDA) has...
Boehringer Ingelheim bags Guinness World Records title for stroke awareness campaign Ruchika Sharma26 Nov 2021 3:35 PM ISTNew Delhi: Boehringer Ingelheim India, has recently announced that the company has achieved the Guinness World Records title for "Most...
